;redcap_repeat_instrument;line_number;line_indication;CIAH;associated_chip;chemotherapy_type;targeted_therapy_type;chip_type;immunotherapy_type;first_dose_date;last_dose_date;stop_chemotherapy_cause;neurotoxicity;progression_date;progression_type;chemotherapy_RECIST_response;PFS;intra_arterial_chemotherapy;line_ia_number;chemotherapy_iv_ia;record_id
1;;;induction_or_perioperative;;;oxaliplatine;none;;none;25/06/2021;06/08/2021;stop_chemotherapy_cause_maintenance;grade_2;31/08/2021;progression_metastasis;stable_disease;;;;other;26.0
2;;;induction_or_perioperative;;;folfiri;bevacizumab;;none;;;stop_chemotherapy_cause_instensification;grade_0;;progression_metastasis;partial_response;;;;;26.0
3;;;intensification;;;folfirinox;bevacizumab;;none;;;stop_chemotherapy_cause_progression;grade_1;;progression_metastasis;stable_disease;;;;;26.0
4;;;metastatic;;;folfiri3;aflibercept;;none;;;stop_chemotherapy_cause_AEG;grade_1;;progression_metastasis;progressive_disease;;;;;26.0
